Insulet Issues Voluntary Correction for Millions of Omnipod Pods
Insulet is recalling some insulin pods due to possible leaks causing low insulin delivery and health risks; replacements offered.
/ 1653 items
#XY↓
GeoVax Drops COVID Vaccine to Fast-Track Mpox and Cancer Programs
GeoVax stops COVID vaccine program to focus on mpox/smallpox and cancer drugs, aiming for faster approvals and growth.
Corbus Pharmaceuticals Stock Drops After CRB-701 Trial Update
Corbus drug CRB-701 showed early cancer activity, but mixed results and small trials led stock to drop 26%. Larger study ahead.
FDA Overturns Rejection: Outlook Therapeutics to Resubmit Lytenava in June
Outlook Therapeutics jumps after FDA appeal win; plans June 2026 resubmission of Lytenava, with possible approval in summer.
Eli Lilly Spends Nearly $4 Billion to Enter the Vaccine Market
Eli Lilly is buying 3 vaccine firms for up to $4B to expand beyond diabetes and obesity into infectious disease vaccines.
Jefferies Sees Hemlibra-Like Potential in Hemab Therapeutics, Starts Coverage with Buy Rating
Hemab targets rare bleeding diseases with new treatments, strong cash, and big growth potential, with analysts seeing ~50% upside.